Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74:229–63.

Article  Google Scholar 

Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, et al. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy. Nature. 2016;533:547–51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sullivan WJ, Mullen PJ, Schmid EW, Flores A, Momcilovic M, Sharpley MS, et al. Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization. Cell. 2018;175:117–32.e21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019;566:403–6.

Article  PubMed  PubMed Central  Google Scholar 

Mossmann D, Müller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068–83.e23.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ricci L, Stanley FU, Eberhart T, Mainini F, Sumpton D, Cardaci S. Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis. Cell Death Dis. 2023;14:403.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li N, Xu X, Liu D, Gao J, Gao Y, Wu X, et al. The delta subunit of the GABA(A) receptor is necessary for the GPT2-promoted breast cancer metastasis. Theranostics. 2023;13:1355–69.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mitra D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, Wilhelm H, Tarade N, et al. Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. Int J Cancer. 2021;148:1993–2009.

Article  PubMed  CAS  Google Scholar 

Li J, Qin Z, Li Y, Huang B, Xiao Q, Chen P, et al. Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer. Adv Sci. 2024;11:e2310208.

Article  Google Scholar 

Zarei M, Hajihassani O, Hue JJ, Loftus AW, Graor HJ, Nakazzi F, et al. IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer. Cancer Res. 2024;84:3072–85.

Li JJ, Yu T, Zeng P, Tian J, Liu P, Qiao S, et al. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nat Commun. 2024;15:3445.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Spitz F, Demignon J, Porteu A, Kahn A, Concordet JP, Daegelen D, et al. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc Natl Acad Sci USA. 1998;95:14220–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature. 2003;426:247–54.

Article  PubMed  CAS  Google Scholar 

Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S, et al. Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell. 2018;33:368–85.e7.

Article  PubMed  CAS  Google Scholar 

Liu Y, Kong WY, Yu CF, Shao ZL, Lei QC, Deng YF, et al. SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16. Acta Pharmacologica Sin. 2023;44:853–64.

Article  CAS  Google Scholar 

Liao Y, Liu Y, Shao Z, Xia X, Deng Y, Cai J, et al. A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance. Oncogene. 2021;40:4291–306.

Article  PubMed  CAS  Google Scholar 

Chu Y, Jiang M, Wu N, Xu B, Li W, Liu H, et al. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 2020;10:9830–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Camolotto SA, Belova VK, Torre-Healy L, Vahrenkamp JM, Berrett KC, Conway H, et al. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4. Gut. 2021;70:900–14.

Article  PubMed  CAS  Google Scholar 

Zhu Z, Rong Z, Luo Z, Yu Z, Zhang J, Qiu Z, et al. Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis. Mol Cancer. 2019;18:126.

Article  PubMed  PubMed Central  Google Scholar 

Liao Y, Sun W, Shao Z, Liu Y, Zhong X, Deng Y, et al. A SIX1 degradation inducer blocks excessive proliferation of prostate cancer. Int J Biol Sci. 2022;18:2439–51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Al-Ubaidi FL, Schultz N, Loseva O, Egevad L, Granfors T, Helleday T. Castration therapy results in decreased Ku70 levels in prostate cancer. Clin Cancer Res. 2013;19:1547–56.

Article  PubMed  CAS  Google Scholar 

Jin S, Weaver DT. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. EMBO J. 1997;16:6874–85.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang Q, Xu J, Gu J, Shi H, Zhang J, Zhang J, et al. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Adv Sci. 2022;9:e2201609.

Article  Google Scholar 

Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019;571:127–31.

Article  PubMed  CAS  Google Scholar 

Kim M, Gwak J, Hwang S, Yang S, Jeong SM. Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism. Oncogene. 2019;38:4729–38.

Article  PubMed  CAS  Google Scholar 

Wang CA, Jedlicka P, Patrick AN, Micalizzi DS, Lemmer KC, Deitsch E, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Investig. 2012;122:1895–906.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Iwanaga R, Wang CA, Micalizzi DS, Harrell JC, Jedlicka P, Sartorius CA, et al. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res. 2012;14:R100.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu K, Li Z, Cai S, Tian L, Chen K, Wang J, et al. EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1. Cancer Res. 2013;73:4488–99.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsu JY, Danis EP, Nance S, O’Brien JH, Gustafson AL, Wessells VM, et al. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state. Cell Rep. 2022;38:110323.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu W, Gao M, Li L, Chen Y, Fan H, Cai Q, et al. Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens. Cell Mol Immunol. 2021;18:2660–72.

Article  PubMed  PubMed Central  CAS  Go